Dx Stage 4 Gl 9 bone mets only, PSA 41, 6 cy. docataxel, leuprolide since 10/16, PSA 1.2, doubled in a year, added bicalutamide, doubled in a year, swapped out Casodex for enzalutamide, roughly half way through the Provenge thang.
Plan to pause Lupron/Xtandi for 2 quarters, receive SBRT in Sep, cavitaxel w/carboplatin/resume Lupron/Xtandi in Oct with Avodart.
The rationale is that the stinking crab cells are adding the adaptive gene to their long, chromosomal "tail" (roughly) annually (for me), a met or two springs up each double (detectable mets). I picture the process as a tree with "blight spots" as the mets, which are dormant during most of the treatment phase prior to the cell's adaptation/conversion. So, I'm thinking to use enough Grays to render the met sites and gland peranently dormant, while using max tolerable dosages of the ADT(s) for 9 months only. Then I take a vaycay and repeat the cycle with new ADT' s each time. The breaks give my organs a rest, I can regain top physical conditioning, and the little SOB's will barely have time to add on to their tails when they get waylaid by a new weapon (apalutamide, et al.) each iteration.
Nous Defions
Crabcrusher